Home
Home » companies

Medicis

Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara

Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara
Pharmabiz

Valeant Earnings Seen Rising As Firm Digests Medicis

Valeant Earnings Seen Rising As Firm Digests Medicis
Investors.com

Valeant cuts 200 Medicis jobs as $2.6B deal closes

Valeant cuts 200 Medicis jobs as $2.6B deal closes
Fierce Pharma

Medicis Pharmaceutical Larger Than S&P 500 Component Pitney Bowes

Medicis Pharmaceutical Larger Than S&P 500 Component Pitney Bowes
Forbes

Medicis hands back next-gen botox rights, settles up with Revance

Medicis hands back next-gen botox rights, settles up with Revance
Fierce Biotech

Valeant announces $1.75 bln debt offering to fund Medicis deal

Valeant announces $1.75 bln debt offering to fund Medicis deal
Reuters

Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp.

Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp.
The Street

Valeant: Ready To Leap Long-Term On Latest Acquisition

Valeant: Ready To Leap Long-Term On Latest Acquisition
Seeking Alpha

Valeant Leaps to No. 1 in Dermatology With Medicis Buy

Valeant Leaps to No. 1 in Dermatology With Medicis Buy
Motley Fool

Valeant To Acquire Medicis for $2.6 Billion

Valeant To Acquire Medicis for $2.6 Billion
Forbes